Up a level |
Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2021) The COVID-19 innovation system. Health Affairs, 40 (3). 400 - 409. ISSN 0278-2715
Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835, Sampat, Bhaven N. and Kapczynski, Amy (2020) Patents, trade, and medicines: past, present, and future. Review of International Political Economy, 27 (1). 75 - 97. ISSN 0969-2290
Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 and Sampat, Bhaven N. (2018) Indian pharmaceutical patent prosecution: the changing role of Section 3(d). PLOS ONE, 13 (4). ISSN 1932-6203
Kapczynski, Amy, Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2017) Trade agreements, patents, and drug prices: continuing the debate. Research Paper (572). John M. Olin Center for Studies in Law, Economics, and Public Policy, Yale Law School, New Haven, CT.
Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2017) Secondary pharmaceutical patenting: a global perspective. Research Policy, 46 (3). pp. 693-707. ISSN 0048-7333
Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 and Sampat, Bhaven N. (2015) Drug patenting in India: looking back and looking forward. South Asia @ LSE (09 Nov 2015). Blog Entry.
Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2015) Drug patenting in India: looking back andlooking forward. Nature Reviews: Drug Discovery, 14. pp. 519-520. ISSN 1474-1776
Sampat, Bhaven N. and Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 (2015) TRIPS implementation and secondary pharmaceutical patenting in Brazil and India. Studies in Comparative International Development, 50 (2). pp. 228-257. ISSN 0039-3606
Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835, Sampat, Bhaven N. and Amin, Tahir M. (2012) Balancing innovation and access: India’s pharmaceutical patent laws. (23 Jul 2012). Website.
Sampat, Bhaven N., Shadlen, Kenneth C. ORCID: 0000-0003-4010-4835 and Amin, Tahir M. (2012) Challenges to India's pharmaceutical patent laws. Science, 337 (6093). pp. 414-415. ISSN 0036-8075